Please login to the form below

Not currently logged in
Email:
Password:

Boehringer launches Facebook game

Syrum aims to teach players about the complexity of medicine development

Boehringer facebook syrum 

German drug maker Boehringer Ingelheim has launched its highly anticipated 'social game' Syrum across Europe.

Developed as an application for Facebook, Syrum is the first of its kind for the pharma industry and aims to educate players through a combination of gaming and social interactivity.

Unveiled at a consumer-style launch at the London Science Museum, the game spent more than two years in development and has been designed to help explain some of the processes of medicine research.

"The use of gaming in education has been put to effective use all over the world as more organisations appreciate that humans are better motivated and stimulated by interaction, fun and engagement", said Dr Jez Rose, behavioural psychologist from Buckinghamshire.

"Syrum is a fantastic example of how fun gaming can be used to provide educational delivery, whilst maintaining interest and engagement through a logical platform-learning style."

Based around a virtual laboratory, Syrum players can develop their own imaginary medicines based around molecular compounds that can also be traded with other players.

"The research driven pharmaceutical industry is immersed in education – whether aimed at medical or pharmaceutical professionals or providing information directly to the public," said John Pugh, director of digital, Boehringer.

"Gaming is an experimental way for Boehringer Ingelheim to do this. The challenge is to do this in a truly engaging, educational and entertaining way that immerses the player."

Built into Facebook, Syrum has initially been launched in a beta format outside the US and Canada, but the company is planning a full global launch next year.

14th September 2012

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...